Metabolic signatures associated with oncolytic myxoma viral infections

Oncolytic viral therapy is a recent advance in cancer treatment, demonstrating promise as a primary treatment option. To date, the secondary metabolic effects of viral infection in cancer cells has not been extensively studied. In this work, we have analyzed early-stage metabolic changes in cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahar, Rohit, Ragavan, Mukundan, Chang, Mario C., Hardiman, Savannah, Moussatche, Nissin, Behar, Adam, Renne, Rolf, Merritt, Matthew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308783/
https://www.ncbi.nlm.nih.gov/pubmed/35871072
http://dx.doi.org/10.1038/s41598-022-15562-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308783/
https://www.ncbi.nlm.nih.gov/pubmed/35871072
http://dx.doi.org/10.1038/s41598-022-15562-3

Ejemplares similares